Atossa Therapeutics
ATOS
ATOS
52 hedge funds and large institutions have $20.2M invested in Atossa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.29% less ownership
Funds ownership: 12.94% → 12.65% (-0.29%)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
52
Holding in Top 10
–
Calls
$1.38M
Puts
$91K
Top Buyers
| 1 | +$381K | |
| 2 | +$337K | |
| 3 | +$174K | |
| 4 |
VF
Virtu Financial
New York
|
+$109K |
| 5 |
Jane Street
New York
|
+$71K |
Top Sellers
| 1 | -$765K | |
| 2 | -$386K | |
| 3 | -$186K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$124K |
| 5 |
State Street
Boston,
Massachusetts
|
-$56.4K |